Sharma V
Psychiatry and Obstetrics & Gynecology, University of Western Ontario, London, Canada; Mood Disorders Program, Regional Mental Health Care London, 850 Highbury Avenue North, P.O. Box 5532, Station B, London, Ont., Canada N6A 4H1.
Med Hypotheses. 2006;67(5):1142-5. doi: 10.1016/j.mehy.2006.04.058. Epub 2006 Jun 23.
Major depressive disorder is a common psychiatric illness that is considered generally treatable; however, there are some patients who fail to respond in spite of adequate trials of antidepressants. Clinical factors known to contribute to treatment resistance include psychiatric and physical comorbidity, undiagnosed bipolarity, and treatment non-adherence. There is also emerging evidence that the use of antidepressants in some 'unipolar' patients may lead to a pattern of progressive diminution of therapeutic response and ultimately treatment resistance. A large number of these patients may have a bipolar diathesis even though there are no symptoms of hypomanic, manic or mixed episodes. It is hypothesized that the widespread and injudicious use of antidepressants in patients with a bipolar diathesis might result in treatment-induced resistant depression. Furthermore, attempts to manage the antidepressant-led mood instability might cause increased utilisation of other psychotropic drugs including sedative/hypnotics, neuroleptics and mood stabilisers and contribute to polypharmacotherapy.
重度抑郁症是一种常见的精神疾病,通常被认为是可治疗的;然而,有一些患者尽管接受了充分的抗抑郁药物试验,但仍无反应。已知导致治疗抵抗的临床因素包括精神和躯体共病、未诊断出的双相情感障碍以及治疗依从性差。也有新出现的证据表明,在一些“单相”患者中使用抗抑郁药可能会导致治疗反应逐渐减弱并最终产生治疗抵抗的模式。这些患者中有大量可能具有双相素质,即使没有轻躁狂、躁狂或混合发作的症状。据推测,在具有双相素质的患者中广泛且不合理地使用抗抑郁药可能会导致治疗诱发的难治性抑郁症。此外,试图处理由抗抑郁药引起的情绪不稳定可能会导致增加使用包括镇静催眠药、抗精神病药和心境稳定剂在内的其他精神药物,并促成多药联合治疗。